# Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine

> **NCT01738074** · PHASE3 · UNKNOWN · sponsor: **Center for Disease Control and Prevention, Henan Province** · enrollment: 10020 (actual)

## Conditions studied

- Randomized
- Double-blind
- Placebo Control Design

## Interventions

- **BIOLOGICAL:** trivalent rotavirus genetic reassortment vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01738074
- **Lead sponsor:** Center for Disease Control and Prevention, Henan Province
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2014-06
- **Final completion:** 2014-12
- **Target enrollment:** 10020 (ACTUAL)
- **Last updated:** 2012-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01738074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01738074, "Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT01738074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*